On Monday, Amgen, Inc. (NASDAQ:AMGN)’s shares inclined 0.93% to $162.22.
AMG 714 is a Phase 2, anti-IL-15 monoclonal antibody that Celimmune has licensed from Amgen (AMGN) and is developing for the treatment of diet non-responsive celiac disease and Type II refractory celiac disease (RCD II), an in situ small bowel T cell lymphoma.
Celimmune LLC, a clinical development-stage immunotherapy company focused on treating and preventing autoimmune diseases, declared recently that Dr. Francisco Leon, CEO and Chief Medical Officer, will provide an oral presentation on an abstract related to the company’s lead product candidate, AMG 714, at the 16th International Coeliac Disease Symposium (ICDS), June 24, 2015, in Prague, Czech Republic.
Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine.
Pernix Therapeutics Holdings Inc (NASDAQ:PTX)’s shares dropped -5.55% to $5.79.
Bellamy Young, actress and singer, best known for her role as First Lady ‘Mellie’ Grant on ABC’s drama “Scandal”, has partnered with Pernix Therapeutics (PTX), the makers of TREXIMET®, to share her experience with migraines in conjunction with National Migraine Awareness Month. As one of the more than 36 million Americans1 who suffer from migraines, Bellamy hopes to drive national awareness of the impact migraines can have, particularly in the summer when warmer weather and shifts in daily routines may trigger symptoms.
As Bellamy is well aware, the unpredictable, intense pain of migraines often impacts sufferers’ personal and professional lives in a meaningful way. In fact, a new survey conducted by Everyday Health, Inc., on behalf of Pernix Therapeutics revealed that 8 in 10 female migraine sufferers2said having migraines makes them feel less in control of their lives, while half agreed their personal relationships suffer because of their migraines.
The survey also found:
- Female migraine sufferers get frustrated (87%) when they feel like they have done everything right, yet still have migraines.
- While only 36% of physicians ask about how migraines have affected their careers, nearly all (96%) female migraine suffers find it difficult to work when they have migraines and almost half (48%) have missed at least one day of work in the past month due to migraines.
- Migraine suffering moms feel especially guilty (91%) when they miss out on quality time with their children because of their migraines.
Female migraine sufferers spend an average of 4 hours per week planning for a potential migraine and few women (29%) are very satisfied with their prescription medication. Fortunately, there are solutions that may assist manage the unpredictable nature of migraines to allow sufferers to take back control when a migraine starts.
Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells branded and generic pharmaceutical products. The companys product comprise CEDAX, an oral cephalosporin used for the treatment of mild to moderate acute bacterial exacerbations of chronic bronchitis, middle ear infection due to haemophilus influenza, or streptococcus pyogene; Zutripro, Rezira, and Vituz for the relief of cough and nasal congestion; and OMECLAMOX-PAK a gastroenterology product.
At the end of Mondays trade, SeaWorld Entertainment Inc (NYSE:SEAS)‘s shares dipped -0.51% to $19.45.
The Board of Directors of SeaWorld Entertainment, Inc. (SEAS) recently declared a cash dividend of $0.21 per share of common stock. The dividend is payable on July 1, 2015 to shareholders of record at the close of business on June 22, 2015.
SeaWorld Entertainment, Inc. operates as a theme park and entertainment company in the United States. The company operates marine-life theme park under the SeaWorld brand name in Orlando, San Antonio, and San Diego; Busch Gardens theme parks, which are family-oriented destinations with foreign geographic settings in Tampa and Williamsburg; Discovery Cove marine-life theme park in Langhorne; and Sesame Place, a seasonal park in Langhorne.
Equity Residential (NYSE:EQR), ended its Monday’s trading session with -1.50% loss, and closed at $72.96.
Equity Residential (EQR) declared that its Board of Trustees declared dividends on the company’s common and preferred shares. A common share dividend for the second quarter of $0.5525 per share will be paid on July 10, 2015 to shareholders of record on June 26, 2015.
A quarterly dividend of $1.03625 per share will be paid on June 30, 2015 to shareholders of record on June 19, 2015 of the company’s Series K Preferred Shares.
Equity Residential, a real estate investment trust (REIT), engages in the acquisition, development, and administration of multifamily properties in the United States. As of December 31, 2007, it owned and invest
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
